SPY326.54-3.44 -1.04%
DIA265.06-1.53 -0.57%
IXIC10,911.59-274.00 -2.45%

JP Morgan Upgrades PTC Therapeutics to Overweight

JP Morgan analyst Eric Joseph upgrades PTC Therapeutics (NASDAQ:PTCT) from Neutral to Overweight.

· 10/07/2020 05:03
JP Morgan analyst Eric Joseph upgrades PTC Therapeutics (NASDAQ:PTCT) from Neutral to Overweight.